ECM
ETNB

ExodusPoint Capital Management’s 89bio ETNB Stock Holding History

ExodusPoint Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-871,404
Closed -$6.45M – 1664
2024
Q3 		$6.45M Buy
871,404
+412,174
+90% +$3.47M 0.04% 328
2024
Q2 		$3.68M Buy
459,230
+442,245
+2,604% +$3.95M 0.03% 540
2024
Q1 		$198K Sell
16,985
-18,233
-52% -$202K ﹤0.01% 1356
2023
Q4 		$393K Buy
+35,218
New +$324K ﹤0.01% 1105
2023
Q2 		– Sell
-227,089
Closed -$3.46M – 1958
2023
Q1 		$3.46M Buy
+227,089
New +$2.96M 0.03% 659
2020
Q4 		– Sell
-39,996
Closed -$1.03M – 2069
2020
Q3 		$1.03M Buy
+39,996
New +$1.27M 0.02% 670

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ExodusPoint Capital Management's ETNB Position: Q4 2024 in Review

ExodusPoint Capital Management sold out of 89bio (ETNB) in Q4 2024, closing a stake of 871,404 shares — an estimated $6.45M sold.

ExodusPoint Capital Management first reported a position in ETNB in Q3 2020 and held it in 6 quarters. The position peaked at $6.45M in Q3 2024. 155 funds tracked by Wall St. Rank hold ETNB as of Q4 2024.

  • ExodusPoint Capital Management reported no remaining 89bio position as of Q4 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 871,404 89bio shares in Q4 2024, an estimated $6.45M.
  • ExodusPoint Capital Management first reported a position in 89bio in Q3 2020 and held it in 6 quarters.
  • ExodusPoint Capital Management's 89bio position peaked at $6.45M in Q3 2024.
  • 155 funds tracked by Wall St. Rank held 89bio as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.